SCHEMBL18936948

SCHEMBL18936948

Nc1ncc(-c2ccc(S(=O)(=O)NC3CC3)cc2)nc1-c1ccc2c(c1)C1(CC1)CNC2=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 10/20 0.43
▸ PIK3CA P42336 3/20 0.43
▸ KCNH2 Q12809 3/20 0.42
▸ PIK3CD O00329 10/20 0.40
▸ PIK3R2 O00459 1/20 0.40
▸ PIK3R1 P27986 1/20 0.40
▸ PIK3R3 Q92569 1/20 0.40
▸ PIK3CB P42338 8/20 0.38
▸ ALOX5AP P20292 2/20 0.38
▸ FEN1 P39748 2/20 0.38
▸ ATR Q13535 2/20 0.37
▸ PIK3C3 Q8NEB9 1/20 0.37
▸ MTOR P42345 2/20 0.37
▸ PRKDC P78527 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ MAP2K7 O14733 1/20 0.36
▸ MAP2K4 P45985 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12496252 0.90 KCNH2 (0.44) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL18937000 0.88 PIK3CG (0.42) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL18937024 0.87 KCNH2 (0.56) PIK3CGKCNH2PIK3CDPIK3CBPIK3C3
SCHEMBL12078764 0.86 PIK3CG (0.44) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL12495701 0.84 KCNH2 (0.46) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL18936981 0.84 KCNH2 (0.39) KCNH2ALOX5APFEN1ATRPRKDC
SCHEMBL12495772 0.84 KCNH2 (0.45) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL12495821 0.83 KCNH2 (0.45) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL18936946 0.83 MAPK1 (0.48) PIK3CGPIK3CAKCNH2PIK3CDPIK3R2
SCHEMBL18937005 0.82 NOS1 (0.38) KCNH2ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2681206-B1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS INC (US) 2017-06-14 — — EP disclosed
Send feedback